Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5

The Antiphospholipid Syndrome

Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,524 · see citing works

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 974 · see citing works

Acquired inhibitors of blood coagulation.

Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521 · see citing works

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism

Rand, J. H., Wu, X.-X., Andree, H. A. M., Lockwood, C. J., Guller, S. M., Scher, J., & Harpel, P. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370303 · Cited by 519 · see citing works

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

de Laat, B., Derksen, R. H. W. M., Urbanus, R. T., & de Groot, P. G. (2005) · Blood · doi:10.1182/blood-2004-09-3387 · Cited by 378 · see citing works

Progress in Hemostasis and Thrombosis.

(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-1-144_1 · Cited by 348 · see citing works

Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus

Horbach, D. A., van Oort, E., Donders, R. C. J. M., Derksen, R. H. W. M., & de Groot, P. G. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650686 · Cited by 246 · see citing works

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphos pholipid antibodies and recurrent spontaneous abortion

Rand, J. H., Wu, X.-X., Guller, S. M., Gil, J., Guha, A., Scher, J., & Lockwood, C. J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90403-0 · Cited by 229 · see citing works

Clustering of lipid-bound annexin V may explain its anticoagulant effect.

Andree, H. A. M., Stuart, M. C. A., Hermens, W. T., Reutelingsperger, C. P. M., Hemker, H. C., Frederik, P. M., & Willems, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37128-5 · Cited by 228 · see citing works

β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219 · see citing works

Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′

Lutters, B. C. H., Derksen, R. H. W. M., Tekelenburg, W. L. H., Lenting, P. J., Arnout, J., & de Groot, P. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212655200 · Cited by 209 · see citing works

Growth of Protein 2-D Crystals on Supported Planar Lipid Bilayers Imagedin Situby AFM

Reviakine, I., Bergsma‐Schutter, W., & Brisson, A. R. (1998) · Journal of Structural Biology · doi:10.1006/jsbi.1998.4003 · Cited by 194 · see citing works

Immunological specificity and mechanism of action of IgG lupus anticoagulants

Pengo, V., Thiagarajan, P., Shapiro, S., & Heine, M. (1987) · Blood · doi:10.1182/blood.v70.1.69.69 · Cited by 194 · see citing works

Placental anticoagulant proteins: isolation and comparative characterization of four members of the lipocortin family

Tait, J. F., Sakata, M., McMullen, B. A., Miao, C. H., Funakoshi, T., Hendrickson, L. E., & Fujikawa, K. (1988) · Biochemistry · doi:10.1021/bi00417a011 · Cited by 180 · see citing works

Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers

Rand, J. H., Wu, X.-X., Quinn, A. S., Chen, P. P., McCrae, K. R., Bovill, E. G., & Taatjes, D. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63479-7 · Cited by 161 · see citing works

Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.

Gris, J., Quéré, I., Sanmarco, M., Boutiere, B., Mercier, É., Amiral, J., Hubert, A., Ripart-Neveu, S., Hoffet, M., Tailland, M.-L., et al. (2000) · PubMed · Cited by 135 · see citing works

NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 Antibodies

Dunoyer-Geindre, S., de Moerloose, P., Rochemonteix, B. G.-D., Reber, G., & Kruithof, E. K. O. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613313 · Cited by 125 · see citing works

Antiphospholipid and Antiprotein Syndromes in Non-thrombotic, Non-autoimmune Women with Unexplained Recurrent Primary Early Foetal Loss

Quéré, I., Sanmarco, M., Boutiere, B., Mercier, É., Amiral, J., Hubert, A.-M., Ripart-Neveu, S., Hoffet, M., Tailland, M.-L., Rousseau, O., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614001 · Cited by 112 · see citing works

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi

Rand, J. H., Wu, X.-X., Guller, S. M., Scher, J., Andree, H. A. M., & Lockwood, C. J. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70294-1 · Cited by 108 · see citing works

Endothelial cell activation by antiphospholipid antibodies

Meroni, P. L., Raschi, E., Testoni, C., & Borghi, M. O. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.015 · Cited by 105 · see citing works

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome

Rand, J. H. (2004) · Blood · doi:10.1182/blood-2004-01-0203 · Cited by 104 · see citing works

Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation

Vogt, E., Ng, A., & Rote, N. S. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70302-8 · Cited by 102 · see citing works

Decreased Binding of Annexin V to Endothelial Cells

Cederholm, A., Svenungsson, E., Jensen‐Urstad, K., Trollmo, C., Ulfgren, A., Swedenborg, J., Fei, G., & Frostegård, J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000150415.18759.36 · Cited by 92 · see citing works

Dimers of β2-Glycoprotein I Mimic thein Vitro Effects of β2-Glycoprotein I-Anti-β2-glycoprotein I Antibody Complexes

Lutters, B. C. H., Meijers, J. C. M., Derksen, R. H. W. M., Arnout, J., & de Groot, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008224200 · Cited by 73 · see citing works

Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.

George, J., Gilburd, B., Hojnik, M., Levy, Y. M., Langevitz, P., Matsuura, E., Koike, T., & Shoenfeld, Y. (1998) · PubMed · Cited by 72 · see citing works

Competition of Annexin V and Anticardiolipin Antibodies for Binding to Phosphatidylserine Containing Membranes

Willems, G. M., Janssen, M. P., Comfurius, P., Galli, M., Zwaal, R. F. A., & Bevers, E. M. (2000) · Biochemistry · doi:10.1021/bi9921081 · Cited by 58 · see citing works

Target Recognition of β2-Glycoprotein I (β2GPI)-Dependent Anticardiolipin Antibodies: Evidence for Involvement of the Fourth Domain of β2GPI in Antibody Binding

George, J., Gilburd, B., Hojnik, M., Levy, Y. M., Langevitz, P., Matsuura, E., Koike, T., & Shoenfeld, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3917 · Cited by 58 · see citing works

Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.

Chopra, N., Koren, S., Greer, W. L., Fortin, P. R., Rauch, J., Fortin, I., Senécal, J., Docherty, P., & Hanly, J. G. (2002) · PubMed · Cited by 50 · see citing works

Antiphospholipid antibody syndrome: Rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies

Tomer, A. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121551 · Cited by 26 · see citing works

Procoagulant Effect of Anti–β2-Glycoprotein I Antibodies With Lupus Anticoagulant Activity

Pengo, V., Brocco, T., Biasiolo, A., Rampazzo, P., Carraro, P., & Zamarchi, R. (1999) · Blood · doi:10.1182/blood.v94.11.3814 · Cited by 23 · see citing works

The influence of anti‐endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells

Patterson, A. M., Ford, I., Graham, A., Booth, N. A., & Greaves, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05994.x · Cited by 19 · see citing works

Untitled work

Wilson (1999) · doi:10.1002/1529-0131(199907)42:7

The Pathogenesis of the Antiphospholipid Syndrome

Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 682 · see citing works

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

Bertolaccini, M. L., Amengual, O., Andreoli, L., Atsumi, T., Chighizola, C. B., Forastiero, R., de Groot, P., Lakos, G., Lambert, M., Meroni, P., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.001 · Cited by 266 · see citing works

β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Ağar, Ç., OS, G. M. A. V., Mörgelin, M., Sprenger, R. R., Marquart, J. A., Urbanus, R. T., Derksen, R. H. W. M., Meijers, J. C. M., & de Groot, P. G. (2010) · Blood · doi:10.1182/blood-2009-12-260976 · Cited by 262 · see citing works

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

Rand, J. H., Wu, X.-X., Quinn, A. S., Ashton, A. W., Chen, P. P., Hathcock, J. J., Andree, H. A. M., & Taatjes, D. J. (2010) · Blood · doi:10.1182/blood-2009-04-213520 · Cited by 253 · see citing works

Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2

Ramesh, S., Morrell, C. N., Tarango, C., Thomas, G. D., Yuhanna, I. S., Girardi, G., Herz, J., Urbanus, R. T., de Groot, P. G., Thorpe, P. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39828 · Cited by 195 · see citing works

‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

Pierangeli, S., de Groot, P. G., Dlott, J. S., Favaloro, E. J., Harris, E., Lakos, G., Ortel, T. L., Meroni, P. L., Otomo, K., Pengo, V., et al. (2011) · Lupus · doi:10.1177/0961203310395055 · Cited by 179 · see citing works

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS

McDonnell, T. C. R., Wincup, C., Buchholz, I., Pericleous, C., Giles, I., Ripoll, V. M., Cohen, H., Delcea, M., & Rahman, A. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100610 · Cited by 169 · see citing works

‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

Bertolaccini, M. L., Amengual, O., Atsumi, T., Binder, W., de Laat, B., Forastiero, R. R., Kutteh, W. H., Lambert, M., Matsubayashi, H., Murthy, V. L., et al. (2011) · Lupus · doi:10.1177/0961203310397082 · Cited by 148 · see citing works

The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis

Rand, J., Xx, W., Quinn, A., & Taatjes, D. J. (2010) · Lupus · doi:10.1177/0961203310361485 · Cited by 143 · see citing works

IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis

Kelchtermans, H., Pelkmans, L., de Laat, B., & Devreese, K. M. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13379 · Cited by 131 · see citing works

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

Tripodi, A., de Groot, P. G., & Pengo, V. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02362.x · Cited by 113 · see citing works

Seronegative antiphospholipid syndrome

Nayfe, R., Uthman, I. W., Aoun, J., Aldin, E. S., Merashli, M., & Khamashta, M. A. (2013) · Rheumatology · doi:10.1093/rheumatology/ket126 · Cited by 109 · see citing works

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy

Fleetwood, T., Cantello, R. M., & Comi, C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01001 · Cited by 98 · see citing works

Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism

de Laat, B., Mertens, K., & de Groot, P. G. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0740 · Cited by 90 · see citing works

Antiphospholipid syndrome: Laboratory testing and diagnostic strategies

Ortel, T. L. (2012) · American Journal of Hematology · doi:10.1002/ajh.23196 · Cited by 75 · see citing works

Antiphospholipid antibodies and malignancies

Tincani, A., Taraborelli, M., & Cattaneo, R. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.04.001 · Cited by 76 · see citing works

New autoantigens in the antiphospholipid syndrome

Alessandri, C., Conti, F., Pendolino, M., Mancini, R., & Valesini, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.011 · Cited by 75 · see citing works

Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review

Radin, M., Cecchi, I., Roccatello, D., Meroni, P. L., & Sciascia, S. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1603936 · Cited by 68 · see citing works

New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies

Chighizola, C. B., Gerosa, M., & Meroni, P. L. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-013-0402-7 · Cited by 64 · see citing works

Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome

Rand, J., Xx, W., Quinn, A., & Taatjes, D. J. (2008) · Lupus · doi:10.1177/0961203308095029 · Cited by 62 · see citing works

Antiphospholipid syndrome and kidney disease

Bienaimé, F., Legendre, C. M., Terzi, F., & Canaud, G. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.026 · Cited by 61 · see citing works

Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots

Tung, M. L., Tan, B. W. Q., Cherian, R., & Chandra, B. (2021) · Rheumatology Advances in Practice · doi:10.1093/rap/rkaa081 · Cited by 58 · see citing works

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

Raschi, E., Borghi, M. O., Tedesco, F., & Meroni, P. L. (2024) · Rheumatology · doi:10.1093/rheumatology/kead603 · Cited by 56 · see citing works

Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography

Devreese, K. M. J., Peerlinck, K., Arnout, J., & Hoylaerts, M. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-06-0393 · Cited by 57 · see citing works

Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage

Carecchio, M., Cantello, R. M., & Comi, C. (2014) · Journal of Immunology Research · doi:10.1155/2014/239398 · Cited by 46 · see citing works

Antiphospholipid antibodies: Paradigm in transition

Horstman, L. L., Jy, W., Bidot, C., Ahn, Y. S., Kelley, R. E., Zivadinov, R., Maghzi, A. H., Etemadifar, M., Mousavi, S. A., & Minagar, A. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-3 · Cited by 46 · see citing works

Procoagulant platelets: Generation, characteristics, and therapeutic target

Chu, Y., Guo, H., Zhang, Y., & Qiao, R. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23750 · Cited by 44 · see citing works

Pathophysiology of Antiphospholipid Syndrome

Green, D. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1701-2809 · Cited by 44 · see citing works

European attempts for the standardisation of the antiphospholipid antibodies

Tincani, A., Filippini, M., Scarsi, M., Galli, M., & Meroni, P. L. (2009) · Lupus · doi:10.1177/0961203309106919 · Cited by 40 · see citing works

Molecular Mechanisms of “Antiphospholipid Antibodies” and Their Paradoxical Role in the Pathogenesis of “Seronegative APS”

Misasi, R., Longo, A., Recalchi, S., Caissutti, D., Riitano, G., Manganelli, V., Garofalo, T., Sorice, M., & Capozzi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218411 · Cited by 40 · see citing works

Pathophysiological mechanisms in antiphospholipid syndrome

Harper, B. E., Willis, R., & Pierangeli, S. S. (2011) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.9 · Cited by 37 · see citing works

Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome

Yin, D., de Groot, P. G., Ninivaggi, M., Devreese, K. M. J., & de Laat, B. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1344-4271 · Cited by 36 · see citing works

Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases

Roux-Lombard, P., Pagano, S., Montecucco, F., Satta, N., & Vuilleumier, N. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8233-z · Cited by 36 · see citing works

Current Controversies in Lupus Anticoagulant Detection

Moore, G. (2016) · Antibodies · doi:10.3390/antib5040022 · Cited by 36 · see citing works

Absence of Distinct Immunohistochemical Distribution of Annexin A5, C3b, C4d, and C5b-9 in Placentas From Patients With Antiphospholipid Antibodies, Preeclampsia, and Systemic Lupus Erythematosus

Matrai, C. E., Rand, J. H., & Baergen, R. N. (2019) · Pediatric and Developmental Pathology · doi:10.1177/1093526619836025 · Cited by 36 · see citing works

From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: Pathogenic mechanisms of the antiphospholipid syndrome

Du, V. X., Kelchtermans, H., de Groot, P. G., & de Laat, B. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.023 · Cited by 35 · see citing works

Treatment of antiphospholipid syndrome beyond anticoagulation

Dobrowolski, C., & Erkan, D. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.03.001 · Cited by 35 · see citing works

Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?

Belizna, C. C., Stojanovich, L., Tervaert, J. W. C., Fassot, C., Henrion, D., Loufrani, L., Nagy, G., Muchardt, C., Hasan, M., Ungeheuer, M. N., et al. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.027 · Cited by 34 · see citing works

Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review

Man, Y. L., & Sanna, G. (2022) · Brain Sciences · doi:10.3390/brainsci12010091 · Cited by 34 · see citing works

Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome

Noureldine, M. H. A., Nour‐Eldine, W., Khamashta, M. A., & Uthman, I. W. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.08.004 · Cited by 33 · see citing works

Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome

Hunt, B. J., Wu, X.-X., de Laat, B., Arslan, A. A., Stuart‐Smith, S., & Rand, J. H. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.019 · Cited by 33 · see citing works

Antiphospholipid antibiodies: a critical review of the literature

Lim, W., & Crowther, M. A. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282a4a65f · Cited by 32 · see citing works

Periodontitis impacts on thrombotic diseases: from clinical aspect to future therapeutic approaches

Ge, J., Zhu, X., Weng, C., Ding, Y. F., Zhao, J., Zhao, L., Wang, T., & Wu, Y. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00325-9 · Cited by 32 · see citing works

Renal involvement in antiphospholipid syndrome

de Azevedo, F. V. A., Maia, D. G., de Carvalho, J. F., & Rodrigues, C. E. M. (2018) · Rheumatology International · doi:10.1007/s00296-018-4040-2 · Cited by 29 · see citing works

The role of anti-phospholipid antibodies in autoimmune reproductive failure

Pantham, P., Abrahams, V. M., & Chamley, L. (2016) · Reproduction · doi:10.1530/rep-15-0545 · Cited by 28 · see citing works

Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I

Wahezi, D. M., Nt, I., Xx, W., Pelkmans, L., de Laat, B., Schanberg, L. E., Rand, J., & for the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators (2013) · Lupus · doi:10.1177/0961203313490241 · Cited by 27 · see citing works

Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome

Yang, L., Guo, R., Liu, H., Chen, B., Li, C., Liu, R., Liao, S., Xie, Q., & Yin, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1527554 · Cited by 28 · see citing works

Significance of fully automated tests for the diagnosis of antiphospholipid syndrome

Oku, K., Amengual, O., Kato, M., Bohgaki, T., Horita, T., Yasuda, S., Sakamoto, N., Ieko, M., Norman, G. L., & Atsumi, T. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.08.018 · Cited by 25 · see citing works

Mechanisms of Cellular Activation in the Antiphospholipid Syndrome

Müller‐Calleja, N., & Lackner, K. J. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1597290 · Cited by 25 · see citing works

Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool

Tomer, A., Bar-Lev, S., Fleisher, S., Shenkman, B., Friger, M. D., & Abu‐Shakra, M. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06751.x · Cited by 25 · see citing works

Acute Prognostic Factors for Post-Thrombotic Syndrome in Children with Limb DVT: A Bi-Institutional Cohort Study

Lyle, C. A., Gibson, E., Lovejoy, A. E., & Goldenberg, N. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.10.012 · Cited by 23 · see citing works

The Future of Antiphospholipid Antibody Testing

de Groot, P. G., & Urbanus, R. T. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1304715 · Cited by 22 · see citing works

Purpura and Microvascular Occlusion

Cox, N. H., & Piette, W. W. (2010) · doi:10.1002/9781444317633.ch49 · Cited by 20 · see citing works

The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome

Chayouâ, W., Kelchtermans, H., & de Laat, B. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1601329 · Cited by 19 · see citing works

Recent advances in understanding antiphospholipid syndrome

Bertolaccini, M. L., & Sanna, G. (2016) · F1000Research · doi:10.12688/f1000research.9717.1 · Cited by 19 · see citing works

The pathogenesis of obstetric APS: a 2023 update

Mineo, C., Shaul, P. W., & Bermas, B. L. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109745 · Cited by 23 · see citing works

Viewpoint: The value of non-criteria antiphospholipid antibodies

de Laat, B., Gehlen, R., & de Groot, P. G. (2024) · Lara D. Veeken · doi:10.1093/rheumatology/kead632 · Cited by 14 · see citing works

Hydroxychloroquine : une nouvelle approche thérapeutique des manifestations thrombotiques du syndrome des antiphospholipides

Szymezak, J., Ankri, A., Fischer, A., & Darnige, L. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.08.018 · Cited by 14 · see citing works

Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects

Amiral, J., Peyrafitte, M., Dunois-Lardé, C., Vissac, A. M., & Seghatchian, J. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2017.07.014 · Cited by 15 · see citing works

The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome

Bećarević, M. B., Stojanovich, L., Ignjatović, S., & Dopsaj, V. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3230-0 · Cited by 13 · see citing works

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I

McDonnell, T. C. R., Artım-Esen, B., Wincup, C., Ripoll, V. M., Isenberg, D. A., Giles, I., Rahman, A., & Pericleous, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02244 · Cited by 13 · see citing works

Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome

Ghelfenstein-Ferreira, T., Delhommeau, F., Johanet, C., Gerotziafas, G., Bornes, M., Cohen, J., Kayem, G., Fain, O., Planche, V., & MEKINIAN, A. (2020) · Clinical Rheumatology · doi:10.1007/s10067-019-04915-5 · Cited by 13 · see citing works

Anti-domain 1 β2 glycoprotein antibodies increase expression of tissue factor on monocytes and activate NK Cells and CD8+ cells in vitro

Manukyan, G. P., Martirosyan, A., Slavík, L., Margaryan, S., Úlehlová, J., Mikulková, Z., Hluší, A., Papajík, T., & Kriegová, E. (2020) · Autoimmunity Highlights · doi:10.1186/s13317-020-00128-y · Cited by 14 · see citing works

Ischemic Stroke: An Underestimated Complication of COVID-19

Cao, W., Zhang, C., Wang, H., Wu, Q., Yuan, Y., Chen, J., Geng, S., & Zhang, X. (2021) · Aging and Disease · doi:10.14336/ad.2021.0209 · Cited by 14 · see citing works

Anticorps antiphospholipides et hémostase

Masliah‐Planchon, J., & Darnige, L. (2011) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2011.10.008 · Cited by 12 · see citing works

Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study

Arvanitakis, Z., Brey, R. L., Rand, J. H., Schneider, J. A., Leurgans, S. E., Yu, L., Buchman, A. S., Arfanakis, K., Fleischman, D. A., Boyle, P. A., et al. (2012) · Neuroepidemiology · doi:10.1159/000342761 · Cited by 12 · see citing works

Domain I: the hidden face of antiphospholipid syndrome

Pericleous, C., & Rahman, A. (2014) · Lupus · doi:10.1177/0961203314540354 · Cited by 11 · see citing works

Paradoxes in dermatology

Adya, K. A., Inamadar, A. C., & Palit, A. (2013) · Indian Dermatology Online Journal · doi:10.4103/2229-5178.110589 · Cited by 11 · see citing works

Antiphospholipid Antibodies in Dogs with Immune Mediated Hemolytic Anemia, Spontaneous Thrombosis, and Hyperadrenocorticism

Miller, A. G., DOW, S. W., Long, L. J., & Olver, C. S. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00922.x · Cited by 11 · see citing works

Antiphospholipid Syndrome

Wysokinska, E. M., & Ortel, T. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00020-0 · Cited by 11 · see citing works

Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte II: síndrome antifosfolípido obstétrico y situaciones especiales

Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2018.11.004 · Cited by 10 · see citing works

Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients

Guo, H., Zhang, Y., Li, A., Wang, C., Yang, S., Zhang, Y., Zhang, J., & Qiao, R. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-019-00555-w · Cited by 9 · see citing works

More about complement in the antiphospholipid syndrome

Timmermans, S. A. M. E. G., Damoiseaux, J. G. M. C., Reutelingsperger, C. P. M., & van Paassen, P. (2020) · Blood · doi:10.1182/blood.2020005171 · Cited by 9 · see citing works

Genetic analysis of ANXA5 haplotype and its effect on recurrent pregnancy loss

Cai, Z., Zheng, X., Chen, Y., Chen, F., Chen, L., & Deng, X. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12559 · Cited by 7 · see citing works

The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies

Rogenhofer, N. N., Engels, L., Bogdanova, N., Tüttelmann, F., Markoff, A., & Thaler, C. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-9978-0 · Cited by 7 · see citing works

Laboratory Tests for the Antiphospholipid Syndrome

Pericleous, C., Ripoll, V. M., Giles, I., & Ioannou, Y. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0326-9_17 · Cited by 8 · see citing works

Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE

Avriel, A., Fleisher, S., Friger, M. D., Shovman, O., Neuman, G., Shoenfeld, Y., & Abu‐Shakra, M. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3428-1 · Cited by 7 · see citing works

Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests

Bertolaccini, M. L., Amengual, O., Artim-Esen, B., Atsumi, T., de Groot, P. G., de Laat, B., Devreese, K. M. J., Giles, I., Meroni, P. L., Borghi, M. O., et al. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_8 · Cited by 6 · see citing works

European Forum on Antiphospholipid Antibodies: research in progress

Meroni, P. L., Tincani, A., Alarcón-Riquelme, M. E., Shoenfeld, Y., & Borghi, M. O. (2009) · Lupus · doi:10.1177/0961203309106916 · Cited by 6 · see citing works

Anticardiolipin from Periodontitis Patients Impact Fetal Loss and Annexin V

Schenkein, H. A., & Thomas, R. R. (2020) · Journal of Dental Research · doi:10.1177/0022034520913244 · Cited by 5 · see citing works

The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus

Matta, B. N., Uthman, I. W., Taher, A. T., & Khamashta, M. A. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.811183 · Cited by 5 · see citing works

Anti-β2-glycoprotein I autoantibodies influence thrombin generation parameters via various mechanisms

Szabó, G., Debreceni, I. B., Tarr, T., Soltész, P., Østerud, B., & Kappelmayer, J. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.10.032 · Cited by 5 · see citing works

Laboratory Diagnosis of Antiphospholipid Syndrome

Reddy, P. (2013) · Southern Medical Journal · doi:10.1097/smj.0b013e31829b9c03 · Cited by 5 · see citing works

Diagnostic significance of anti-annexin-A5 antibody determination

Baleva, M. P., Hristova, M. H., & Nikolov, K. V. (2009) · Open Medicine · doi:10.2478/s11536-009-0132-4 · Cited by 4 · see citing works

The Pathophysiology of Antiphospholipid Syndrome

Sada, P. R., Cohen, H., & Isenberg, D. A. (2015) · The Open Urology & Nephrology Journal · doi:10.2174/1874303x01508010002 · Cited by 4 · see citing works

Pathogenesis of Antiphospholipid Syndrome

Amengual, O., & Atsumi, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00056-5 · Cited by 4 · see citing works

Recommendations of the Spanish Rheumatology Society for primary antiphospholipid syndrome. Part II: Obstetric antiphospholipid syndrome and special situations

Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.013 · Cited by 4 · see citing works

Chapter 4 Mechanisms of Action of Antiphospholipid Antibodies

Raschi, E., Broggini, V., Grossi, C., Borghi, M. O., Pierangeli, S. S., & Meroni, P. L. (2009) · Technical report · doi:10.1016/s1571-5078(08)00404-2 · Cited by 4 · see citing works

Extracellular Vesicles Analysis as Possible Signatures of Antiphospholipid Syndrome Clinical Features

Bonisoli, G. L., Argentino, G., Friso, S., & Tinazzi, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072834 · Cited by 3 · see citing works

Pathogenesis of antiphospholipid syndrome

Amengual, O., & Atsumi, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00058-1 · Cited by 3 · see citing works

Prevalence of Annexin A5 Resistance in Children and Adolescents with Rheumatic Diseases

Wahezi, D. M., Ilowite, N. T., Rajpathak, S. N., & Rand, J. H. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110768 · Cited by 3 · see citing works

Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.

Irman, Š., Škarabot, M., Muševič, I., Rozman, B., & Božič, B. (2011) · PubMed Central · Cited by 3 · see citing works

Self‐interaction of soluble and surface‐bound β2‐glycoprotein I and its enhancement by lupus anticoagulants

Hayashi, A., Hayashi, A., Matsuura, E., Suzuki, K., Koike, T., Hashimoto, E., & Takeya, H. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.09.037 · Cited by 3 · see citing works

Complement involvement in antiphospholipid syndrome

Hamidi, H., Darnige, L., & Dragon‐Durey, M. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107148 · Cited by 2 · see citing works

Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining

Tang, L. F., Li, B., Su, Q., Chen, X., & He, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-39258-4 · Cited by 2 · see citing works

Natural Proteins Involved in Antiphospholipid Syndrome

de Groot, P. G., de Laat, B., Rand, J. H., Vlachoyiannopoulos, P. G., El‐Assaad, F., Krilis, S. A., & Giannakopoulos, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_2 · Cited by 2 · see citing works

Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies

Pierangeli, S. S., & Rand, J. H. (2009) · Technical report · doi:10.1016/s1571-5078(08)00403-0 · Cited by 2 · see citing works

Thrombophilia in Systemic Lupus Erythematosus: A Review of Multiple Mechanisms and Resultant Clinical Outcomes

Patricia, J. K., & Robert, J. (2013) · InTech eBooks · doi:10.5772/56902 · Cited by 2 · see citing works

Chapter 5 Tissue Factor in Antiphospholipid Antibody-induced Pregnancy Loss: Thrombosis versus Inflammation

Girardi, G., & Mackman, N. (2009) · Technical report · doi:10.1016/s1571-5078(08)00405-4 · Cited by 2 · see citing works

Update on antiphospholipid antibodies: clinical significance

Tincani, A., ZIGLIOLI, T., Andréoli, L., & Meroni, P. L. (2009) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.09.38 · Cited by 2 · see citing works

Pathological Anti-β2-Glycoprotein I Antibodies Disrupt the Anticoagulant Activity of Annexin A5: A Possible Explanation for the Lupus Anticoagulant Paradox.

de Laat, B., Wu, X.-X., van Lummel, M., Derksen, R. H. W. M., de Groot, P. G., & Rand, J. H. (2005) · Blood · doi:10.1182/blood.v106.11.135.135

Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C

de Laat, B., Eckmann, C. M., van Schagen, M., Meijer, A. B., Mertens, K., & van Mourik, J. A. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32830f1b85 · Cited by 45 · see citing works

Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I

Oostin, J. D., Derksen, R. H. W. M., Entjes, H. T. I., Bouma, B. N., & de Groot, P. G. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648480 · Cited by 143 · see citing works

Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.

Oosting, J. D., Derksen, R. H. W. M., Entjes, H. T. I., Bouma, B. N., & de Groot, P. G. (1992) · PubMed · Cited by 174 · see citing works

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

Durigutto, P., Grossi, C., Borghi, M. O., Macor, P., Pregnolato, F., Raschi, E., Myers, M. P., de Groot, P. G., Meroni, P. L., & Tedesco, F. (2018) · Haematologica · doi:10.3324/haematol.2018.198119 · Cited by 55 · see citing works